Exact Sciences Corp (NASDAQ: EXAS): To Buy Or Not To Buy, That Is The Question
Exact Sciences Corp (EXAS) concluded trading on Thursday at a closing price of $49.51, with 5.32 million shares of worth about $263.62 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.04% during that period and on February 20, 2025 the price saw a […]
Exact Sciences Corp (NASDAQ: EXAS): Reassessing Prospects
Exact Sciences Corp (EXAS) concluded trading on Thursday at a closing price of $50.44, with 6.05 million shares of worth about $305.19 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.17% during that period and on January 16, 2025 the price saw a […]
Exact Sciences Corp. (NASDAQ: EXAS): Reassessing Prospects
Exact Sciences Corp. (EXAS) concluded trading on Thursady at a closing price of $59.49, with 4.62 million shares of worth about $274.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -27.33% during that period and on Thursady the price saw a loss of […]
Exact Sciences Corp. (NASDAQ: EXAS): Do Not Miss The Gain Train
JPMorgan Investment Management, I has recently announced that it has increased stake in Exact Sciences Corp. (NASDAQ:EXAS) by 24.60%. After grabbing 15.33 million shares, the institutional investor is now in possession of 3.03 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.48% having worth around $981.42 million. […]
